Showing results (571-580 of 858) with videos related to

Sort By:
Pageof 86
Journal of Toxicology. Clinical Toxicology|December 29, 1998
Randomized placebo-controlled trial of 2,3-dimercaptosuccinic acid in therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil waterD N Guha Mazumder, U C Ghoshal, J Saha, et al.
Transplantation Proceedings|September 16, 2008
Generic tacrolimus (Pan Graf) in renal transplantation: an experience of 155 recipients in IndiaS Guleria, M Kamboj, A Chatterjee, et al.
Heart Rhythm O2|October 20, 2021
Catheter ablation of atrial fibrillation results in significant QTc prolongation in the postoperative periodDan D Nguyen, Nazem Akoum, Jonathan Hourmozdi, et al.
The American Journal of Cardiology|June 7, 2016
Usefulness of the Sum Absolute QRST Integral to Predict Outcomes in Patients Receiving Cardiac Resynchronization TherapyJonatan Jacobsson, Rasmus Borgquist, Christian Reitan, et al.
Heart Rhythm O2|August 25, 2020
QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019Arun R Sridhar, Neal A Chatterjee, Basil Saour, et al.
Indian Heart Journal|November 1, 1996
Hypertension in the young in eastern IndiaM Panja, S Kumar, C N Sarkar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 12, 2011
NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and salivaR Guerrero-Preston, E Soudry, J Acero, et al.
International Journal of Cardiology|December 29, 2015
Incremental value of cystatin C over conventional renal metrics for predicting clinical response and outcomes in cardiac resynchronization therapy: The BIOCRT studyNeal A Chatterjee, Jagmeet P Singh, Jackie Szymonifka, et al.
Plos One|October 4, 2019
Can machine learning improve patient selection for cardiac resynchronization therapy?Szu-Yeu Hu, Enrico Santus, Alexander W Forsyth, et al.
Pageof 86